Categories: NewsPharmaceutical

PharmaScroll Launches SocialBI: The Cutting-Edge Social Media Listening Tool for Real-Time Patient Insights

HYDERABAD, India, Jan. 7, 2025 /PRNewswire/ — PharmaScroll, a renowned market research and business analytics organization is thrilled to announce the launch of SocialBI, a comprehensive end to end social media listening tool that combines strong technological expertise and functional Pharma Market Research focus designed to deliver real-time insights into patient behaviour, disease landscape, sentiment analysis, and market trends. SocialBI is set to revolutionize how pharmaceutical companies understand and engage with their audiences.

SocialBI extracts patient and physician conversations from multiple social media channels including X (formerly known as Twitter), Reddit and various Patient forums including Mayo Clinic, Inspire, Health Unlocked, WebMD, and others. Further the tool harnesses advanced data analytics, complex NLP algorithms and Gen AI to monitor and analyze these conversations providing unparalleled insights into patient switch behavior, share of voice (SoV), drug safety & efficacy perceptions, patient journey, and overall sentiments and themes enabling pharmaceutical companies to stay closer to the patients and make data-driven decisions with precision and confidence.

Key Features of SocialBI:

  1. Real-Time Patient Insights : Track and analyze patient behavior and trends as they happen, ensuring timely and relevant responses.
  2. Sentiment Analysis : Gain a deeper understanding of public perception and sentiment towards brands, treatments, and competitors.
  3. Share of Voice : Measure and compare your brand’s presence and influence against competitors in the social media landscape.
  4. Switch Behaviour : Understand patient’s switch behaviour, reason for switch and Source of Business (SoB)
  5. Efficacy & Safety Perception : Comparative efficacy and safety perceptions for market basket, side effects and unmet needs analysis
  6. Comprehensive Analytics : Access detailed reports and visualizations that provide actionable insights and strategic guidance.
  7. User-Friendly Interface : Navigate through a simple and intuitive platform designed for ease of use, even for those new to social media analytics.

“We are excited to bring SocialBI to the market. It represents a transformative tool for pharmaceutical companies aiming to leverage the potential of social media conversational data,” said Sahil Singla, Director of PharmaScroll. “With SocialBI, our clients can stay ahead of trends, understand patient needs better, and enhance their strategic planning and marketing efforts.”

SocialBI is tailored for pharmaceutical companies seeking to improve their market intelligence, optimize patient engagement, and gain a competitive edge. By providing a holistic view of the social media landscape, SocialBI helps companies identify opportunities, analyse unmet needs and mitigate risks effectively.

For more information about SocialBI and to request a demo, please visit https://pharmascroll.com/product/socialbi

About PharmaScroll:

PharmaScroll is a leading market research and business analytics company dedicated to empowering the pharmaceutical industry with actionable insights and strategic support. With a team of industry experts and innovative technology, PharmaScroll delivers comprehensive market intelligence and competitive analysis, enabling clients to make informed decisions and achieve success in the global marketplace.

For media inquiries or additional information about PharmaScroll’s SocialBi Social Listening Platform, please visit our website: PharmaScroll

Media Contact: 
enquiry@pharmascroll.com   
+91 9618379037

Logo: https://healthtechnologynet.com/wp-content/uploads/2025/01/PharmaScroll_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/pharmascroll-launches-socialbi-the-cutting-edge-social-media-listening-tool-for-real-time-patient-insights-302344134.html

SOURCE PharmaScroll

Staff

Recent Posts

RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has…

2 hours ago

ITRI Opens CES 2025 With Trend-Leading Showcase and Partnership With Reliance Biotech Corporation

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) initiated its presence…

2 hours ago

NOTICE OF DATA BREACH

LOS ANGELES, Jan. 8, 2025 /PRNewswire/ -- Dear members of the STIIIZY community:  Stiiizy, Inc.…

2 hours ago

Ascent Strategy Group Recognized by Modern Healthcare’s Best in Business, Affirms Health Equity Mission Amid Alarming Disparities

Agency Founder nominated Outstanding Agency Professional, Innovator of the Year First public relations agency built…

2 hours ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options

VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or…

5 hours ago

cbdMD Announces Additional Conversions of Its Convertible Notes

Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

8 hours ago